9 research outputs found
Chemical Perturbation of Secondary Metabolism Demonstrates Important Links to Primary Metabolism
SummaryBacterially produced secondary metabolites are used as antibiotics, anticancer drugs, and for many other medicinal applications. The mechanisms that limit the production of these molecules in the laboratory are not well understood, and this has impeded the discovery of many important compounds. We have identified small molecules that remodel the yields of secondary metabolites in many actinomycetes and show that one set of these molecules does so by inhibiting fatty acid biosynthesis. This demonstrates a particularly intimate relationship between this primary metabolic pathway and secondary metabolism and suggests an approach to enhance the yields of metabolites for discovery and biochemical characterization
Anti-Parasitic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges
Actinomycetes are prolific producers of pharmacologically important compounds accounting for about 70% of the naturally derived antibiotics that are currently in clinical use. In this study, we report on the isolation of Streptomyces sp. strains from Mediterranean sponges, on their secondary metabolite production and on their screening for anti-infective activities. Bioassay-guided isolation and purification yielded three previously known compounds namely, cyclic depsipeptide valinomycin, indolocarbazole alkaloid staurosporine and butenolide. This is the first report of the isolation of valinomycin from a marine source. These compounds exhibited novel anti-parasitic activities specifically against Leishmania major (valinomycin IC50 < 0.11 ÎĽM; staurosporine IC50 5.30 ÎĽM) and Trypanosoma brucei brucei (valinomycin IC50 0.0032 ÎĽM; staurosporine IC50 0.022 ÎĽM; butenolide IC50 31.77 ÎĽM). These results underscore the potential of marine actinomycetes to produce bioactive compounds as well as the re-evaluation of previously known compounds for novel anti-infective activities
Neue anti-infektive Sekundärmetabolite und biosynthetische Gencluster aus mit marinen Schwämmen assoziierten Actinomyceten
Marine sponges (Porifera) harbor diverse microbial communities within their mesohyl, among them representatives of the phylum Actinobacteria, commonly known as actinomycetes. Actinomycetes are prolific producers of pharmacologically important compounds and are responsible for producing the majority of antibiotics. The main aim of this Ph.D. study was to investigate the metabolic potential of the sponge-associated actinomycetes to produce novel anti-infective agents. The first aim was to cultivate actinomycetes derived from different marine sponges. 16S rDNA sequencing revealed that the strains belonged to diverse actinomycete genera such as Gordonia, Isoptericola, Micromonospora, Nocardiopsis, Saccharopolyspora and Streptomyces. Phylogenetic analyses and polyphasic characterization further revealed that two of these strains represent new species, namely Saccharopolyspora cebuensis strain SPE 10-1T (Pimentel-Elardo et al. 2008a) and Streptomyces axinellae strain Pol001T (Pimentel-Elardo et al. 2008b). Furthermore, secondary metabolite production of the actinomycete strains was investigated. The metabolites were isolated using a bioassay-guided purification scheme followed by structure elucidation using spectroscopic methods and subjected to an elaborate anti-infective screening panel. Several interesting compounds were isolated namely, the novel polyketides cebulactam A1 and A2 (Pimentel-Elardo et al. 2008c), a family of tetromycin compounds including novel derivatives, cyclodepsipeptide valinomycin, indolocarbazole staurosporine, diketopiperazine cycloisoleucylprolyl and butenolide. These compounds exhibited significant anti-parasitic as well as protease inhibitory activities. The third aim of this Ph.D. study was to identify biosynthetic gene clusters encoding for nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) present in the actinomycete strains. Genomic library construction and sequencing revealed insights into the metabolic potential and biosynthetic pathways of selected strains. An interesting NRPS system detected in Streptomyces sp. strain Aer003 was found to be widely distributed in several sponge species, in an ascidian and in seawater and is postulated to encode for a large peptide molecule. Sequencing of the PKS gene cluster of Saccharopolyspora cebuensis strain SPE 10-1T allowed the prediction of the cebulactam biosynthetic pathway which utilizes 3-amino-5-hydroxybenzoic acid as the starter unit followed by successive condensation steps involving methylmalonyl extender units and auxiliary domains responsible for the polyketide assembly. In conclusion, this Ph.D. study has shown that diverse actinomycete genera are associated with marine sponges. The strains, two of them novel species, produced diverse chemical structures with interesting anti-infective properties. Lastly, the presence of biosynthetic gene clusters identified in this study substantiates the biosynthetic potential of actinomycetes to produce exploitable natural products and hopefully provides a sustainable supply of anti-infective compounds.Zahlreiche marine Schwämme (Phylum: Porifera) beherbergen eine phylogenetisch diverse mikrobielle Gemeinschaft in der Mesohyl-Matrix, darunter auch viele Vertreter des bakteriellen Phylums Actinobacteria, die umgangssprachlich als Actinomyceten bekannt sind. Actinomyceten sind wichtige Produzenten vieler Antibiotika und von weiteren pharmazeutisch relevanten Substanzen. Das Hauptziel dieser Promotionsarbeit war die Untersuchung des Potentials Schwamm-assoziierter Actinomyceten zur Produktion neuer Infektions-hemmender Substanzen. Ein erstes Ziel dieser Doktorarbeit war die Kultivierung von Actinomyceten aus verschiedenen marinen Schwammarten. Die Sequenzierung der respektiven 16S rRNA Gene zeigte eine phylogenetische Zugehörigkeit der Isolate zu verschiedenen Actinomyceten-Familien, wie Gordonia, Isoptericola, Micromonospora, Nocardiopsis, Saccharopolyspora und Streptomyces. Durch phylogenetische Analysen und umfangreiche taxonomische Charakterisierungen konnten zwei neue Actinomyceten-Arten, Saccharopolyspora cebuensis strain SPE 10-1T (Pimentel-Elardo et al. 2008a) und Streptomyces axinellae strain Pol001T (Pimentel-Elardo et al. 2008b) beschrieben werden. Des Weiteren sollten die Actinomyceten-Isolate auf die Produktion von Sekundär-Metaboliten hin untersucht werden. Die Substanzen wurden „bioassay-guided“ aufgereinigt und isoliert sowie deren Struktur mittels spektroskopischer Methoden aufgeklärt. Anschließend wurden die Substanzen ausführlichen Screening-Methoden unterzogen, um sie auf anti-infektive Wirkungen hin zu untersuchen. Zahlreiche interessante Verbindungen konnten so isoliert werden, u. a. die neuen Polyketide Cebulactam A1 und A2 (Pimentel-Elardo et al. 2008c); eine Familie von Tetromycin-Substanzen inklusive neuartiger Derivative; das Cyclodepsipeptid Valinomycin, Indolocarbazole Staurosporine, Diketopiperazine Cycloisoleucylprolyl und Butenolide. Die Verbindungen zeigten signifikante anti-parasitische und Protease-hemmende Aktivitäten. Das dritte Ziel dieser Arbeit war es, die für nicht-ribosomale Peptidsynthetasen (NRPS) und Polyketidsynthasen (PKS) kodierenden, biosynthetischen Gen-Cluster in den Actinomyceten-Isolaten zu identifizieren. Die Konstruktion von Genbanken sowie die Sequenzierung ausgewählter Cosmidklone lieferte erste Einblicke in das Stoffwechsel- und Biosynthesepotential ausgewählter Isolate. Beispielsweise konnte ein interessantes NRPS-System in Streptomyces sp. Stamm Aer003 identifiziert werden, welches in verschiedenen Schwammarten, einer Ascidienart sowie im Meerwasser gefunden wurde. Die Sequenzierung eines PKS-Genclusters aus Saccharopolyspora cebuensis strain SPE 10-1T ermöglicht die Voraussage des Cebulactam-Biosynthesewegs in dem 3-Amino-5-Hydroxybenzoesäure als Ausgangsprodukt dient, welches durch sukzessive Kondensationsschritte sowie Verlängerungen durch Methylmalonyl- und Zusatzdomänen zum endgültigen Polyketid führen. Zusammenfassend konnte in dieser Promotionsarbeit gezeigt werden, dass marine Schwämme mit diversen Vertretern aus verschiedenen Familien der Actinomyceten assoziiert sind. Die Bakterienisolate, von denen zwei neue Arten repräsentieren, produzierten mehrere chemische Substanzen mit interessanten anti-infektiven Eigenschaften. Des Weiteren konnte mit dieser Arbeit durch die Identifizierung von Biosynthese-Genclustern das Potential von Actinomyceten zur Produktion verwertbarer bioaktiver Substanzen bekräftigt und somit ein Beitrag zur Entdeckung neuer anti-infektiver Substanzen erbracht werden
Cebulactams A1 and A2, new macrolactams isolated from Saccharopolyspora cebuensis, the first obligate marine strain of the genus Saccharopolyspora
The new macrolactams cebulactams A1 and A2 were isolated from an extract of the first obligate marine strain of the genus Saccharopolyspora. Their constitutionally identical structures, each bearing a six-membered cyclic ether as part of the macrocycle, and their relative configurations were elucidated by MS methods and by 1D and 2D NMR techniques
submitted by
Novel anti-infective secondary metabolites and biosynthetic gene clusters from actinomycetes associated with marine sponges Neue anti-infektive Sekundärmetabolite und biosynthetische Gencluster aus mit marinen Schwämme
Diversity of Nonribosomal Peptide Synthetase Genes in the Microbial Metagenomes of Marine Sponges
Genomic mining revealed one major nonribosomal peptide synthetase (NRPS) phylogenetic cluster in 12 marine sponge species, one ascidian, an actinobacterial isolate and seawater. Phylogenetic analysis predicts its taxonomic affiliation to the actinomycetes and hydroxy-phenyl-glycine as a likely substrate. Additionally, a phylogenetically distinct NRPS gene cluster was discovered in the microbial metagenome of the sponge <em>Aplysina aerophoba</em>,<em> </em>which shows highest similarities to NRPS genes that were previously assigned, by ways of single cell genomics, to a <em>Chloroflexi</em> sponge symbiont. Genomic mining studies such as the one presented here for NRPS genes, contribute to on-going efforts to characterize the genomic potential of sponge-associated microbiota for secondary metabolite biosynthesis
Cyclodysidins A–D, cyclic lipopeptides from the marine sponge-derived Streptomyces strain RV15
Four new cyclic lipopeptides, cyclo-(AFA-Ser-Gln-Asn-Tyr-Asn-Ser-Thr), named cyclodysidins A–D, were isolated from the broth culture of Streptomyces strain RV15 associated with the marine sponge Dysidea tupha. The sequences of the amino acid building blocks in the compounds and their structures were determined by 1D- and 2D-NMR techniques and CID-MS/MS experiments. The absolute configurations of all α-amino acids were determined by HPLC analysis after derivatization with Marfey’s reagent and comparison with commercially available reference samples, while those two of the β-amino fatty acids were determined by using racemic and enantiopure reference samples synthetically prepared
Natural Products Repertoire of the Red Sea
Marine natural products have achieved great success as an important source of new lead compounds for drug discovery. The Red Sea provides enormous diversity on the biological scale in all domains of life including micro- and macro-organisms. In this review, which covers the literature to the end of 2019, we summarize the diversity of bioactive secondary metabolites derived from Red Sea micro- and macro-organisms, and discuss their biological potential whenever applicable. Moreover, the diversity of the Red Sea organisms is highlighted as well as their genomic potential. This review is a comprehensive study that compares the natural products recovered from the Red Sea in terms of ecological role and pharmacological activities